Cardio Oncology

The study of cardiovascular disease that develops as a result of chemotherapy and radiotherapy is the focus of the emerging specialty of cardiology known as cardio-oncology. Cardiovascular disease is also monitored and treated in this setting. A significant source of morbidity and mortality in the oncologic population, cardiac dysfunction can be brought on by either cancer therapy method. It is important to routinely check on cancer patients receiving treatment, especially those getting anthracyclines and trastuzumab (a monoclonal antibody). The main method used for this is 3D echocardiography, which can be used to calculate the left ventricular ejection fraction and gauge myocardial deformation. It may also be possible to detect potential cardio toxicity early and respond appropriately by evaluating different biomarkers, such as natriuretic peptides

    Related Conference of Cardio Oncology

    May 30-31, 2024

    6th Euro Cardiology Congress

    Vienna, Austria
    May 30-31, 2024

    39th World Congress on Heart Diseases

    Vienna, Austria
    June 20-21, 2024

    5th European Summit on Cardiology Research

    Dublin, Ireland
    July 16-17, 2024

    13th World Heart Congress

    Paris, France
    August 01-02, 2024

    38th World Congress on Heart Diseases

    Montreal, Canada
    September 16-17, 2024

    3rd Global Summit on Cardiology and Cardiac Surgery

    Paris, France
    October 24-25, 2024

    11th International Conference on Interventional Cardiology

    Zurich, Switzerland
    October 30-31, 2024

    7th Global Cardiovascular Research and Clinical Cardiology

    Vancouver, Canada

    Cardio Oncology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in